Veterinary Pain Management Drugs Market 2022-2028

Description

List of Tables

Title:Global Veterinary Pain Management Drugs Market Size, Share, and Trends Analysis Report, by Type (NSAIDs, Agonists, Anesthetics, Opioids, DMOADs, and Others), By Animal Type (Companion Animals and Livestock Animals), By Application (Osteoarthritis, Musculoskeletal Disorders, Cancer, and Others), By Distribution Channel (Veterinary Hospitals, Veterinary Clinics, and Others), Forecast Period (2022-2028).

The global veterinary pain management drugs market is anticipated to grow at a substantial CAGR of 3.8% during the forecast period. The global veterinary pain management drugs market growth is driven by the factors such as rising pet owners' inclination toward maintaining animal health and welfare, and the development of better-personalized drugs by prominent players operating in market growth. A significant increase in the livestock population suffering from cancer, and abdominal and neuropathic pain is also creating a positive scope for market growth. According to the American Veterinary Medical Association, nearly 1 in 4 dogs will, at some stage in their life, develop neoplasia. Almost half of the dogs over the age of 10 will develop cancer. Significant investment by pet owners in animal healthcare is the factor motivating drug manufacturers to increase their R&D activities for better drug development. As per the American Pet Products Association, in 2019, annual spending on pets reached nearly $95.7 billion, and animal product sales reached around $100 billion.

The global veterinary pain management drugs market is segmented based on type, animal type, application, and distribution channel. Based on type, the market is sub-segmented into NSAIDs, agonists, anesthetics, opioids, DMOAD, and others. Based on animal type, the market is bifurcated into companion animals and livestock animals. Based on application, the market is sub-segmented into osteoarthritis, musculoskeletal disorders, cancer, and others. Whereas based on distribution channels, the market is further categorized into veterinary hospitals, veterinary clinics, and others.

Geographically, the veterinary pain management drugs market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. North America is likely to hold the highest share in the market due to the huge consumption of dairy products that has surged the number of animals. That further led to the generation of animal diseases. Moreover, many companies in the region are launching new products in the market. For instance, in 2020, Carprofen Chewable Tablets was developed by Cronus Pharma Specialties and approved by the USFDA.

The major market players in the global veterinary pain management drugs market include Zoetis Inc., Merck & Co., Inc., BASF SE, Bayer AG, Boehringer Ingelheim International GmbH, Cargill Inc., Elanco Animal Health Inc., and Eli Lilly and Co., among others. The market players are also contributing significantly to the growth of the market by the adoption of various strategies including mergers and acquisitions, geographical expansion, partnerships, collaborations, and new product launches, to stay competitive in the market.

Research Methodology

The market study of the global veterinary pain management drugs is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to break down the market into various segments, and derive the total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macroeconomic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include:

Financial reports of companies involved in the market.

Whitepapers, research papers, and news blogs.

Company websites and their product catalog.

The report provides an in-depth analysis of the market size and intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

Global Veterinary Pain Management Drugs Research and Analysis by Type
Global Veterinary Pain Management Drugs Research and Analysis by Animal Type
Global Veterinary Pain Management Drugs Research and Analysis by Application
Global Veterinary Pain Management Drugs Research and Analysis by Distribution Channel

The Report Covers:

Comprehensive research methodology of the global veterinary pain management drugs market.
This report also includes a detailed and extensive market overview with key analyst insights.
An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
Analysis of regional regulations and other government policies impacting the global veterinary pain management drugs market.
Insights about market determinants that are stimulating the global veterinary pain management drugs market.
Detailed and extensive market segments with the regional distribution of forecasted revenues.
Extensive profiles and recent developments of market players.

Product Code: OMR2026781

1. Report Summary

Current Industry Analysis and Growth Potential Outlook
1.1. Research Methods and Tools
1.2. Market Breakdown
- 1.2.1. By Segments
- 1.2.2. By Region

2. Market Overview and Insights

2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
- 2.2.1. Key Findings
- 2.2.2. Recommendations
- 2.2.3. Conclusion

3. Competitive Landscape

3.1. Key Company Analysis
- 3.1.1. Zoetis Inc.
  - 3.1.1.1. Overview
  - 3.1.1.2. Financial Analysis
  - 3.1.1.3. SWOT Analysis
  - 3.1.1.4. Recent Developments
- 3.1.2. Merck & Co., Inc.
  - 3.1.2.1. Overview
  - 3.1.2.2. Financial Analysis
  - 3.1.2.3. SWOT Analysis
  - 3.1.2.4. Recent Developments
- 3.1.3. BASF SE
  - 3.1.3.1. Overview
  - 3.1.3.2. Financial Analysis
  - 3.1.3.3. SWOT Analysis
  - 3.1.3.4. Recent Developments
3.2. Key Strategy Analysis

4. Market Segmentation

4.1. Global Veterinary Pain Management Drugs Market by Type
- 4.1.1. NSAIDs (Nonsteroidal Anti-inflammatory Drugs)
- 4.1.2. Agonists
- 4.1.3. Anesthetics
- 4.1.4. Opioids
- 4.1.5. DMOADs (Disease-Modifying Osteoarthritis Drug)
- 4.1.6. Others
4.2. Global Veterinary Pain Management Drugs Market by Animal Type
- 4.2.1. Companion Animal
- 4.2.2. Livestock Animal
4.3. Global Veterinary Pain Management Drugs Market by Application
- 4.3.1. Osteoarthritis
- 4.3.2. Musculoskeletal Disorders
- 4.3.3. Cancer
- 4.3.4. Others
4.4. Global Veterinary Pain Management Drugs Market by Distribution Channel
- 4.4.1. Veterinary Hospitals
- 4.4.2. Veterinary Clinics
- 4.4.3. Others

5. Regional Analysis

5.1. North America
- 5.1.1. United States
- 5.1.2. Canada
5.2. Europe
- 5.2.1. UK
- 5.2.2. Germany
- 5.2.3. Italy
- 5.2.4. Spain
- 5.2.5. France
- 5.2.6. Rest of Europe
5.3. Asia-Pacific
- 5.3.1. China
- 5.3.2. India
- 5.3.3. Japan
- 5.3.4. South Korea
- 5.3.5. Rest of Asia-Pacific
5.4. Rest of the World
- 5.4.1. Latin America
- 5.4.2. Middle East & Africa

6. Company Profiles

6.1. Assisi Animal Health
6.2. Bayer AG
6.3. Boehringer Ingelheim International GmbH
6.4. Cargill Inc.
6.5. Ceva Sante Animale
6.6. Chanelle Pharma
6.7. Dechra Pharmaceuticals
6.8. Elanco Animal Health Inc.
6.9. Eli Lilly and Co.
6.10. Evonik Industries AG
6.11. Idexx Laboratories Inc.
6.12. Kemin Industries, Inc
6.13. Norbrook Laboratories Ltd.
6.14. Sumitomo Chemical Co. Ltd.
6.15. Vetoquinol S.A